Abstracts tagged "Arthroplasty"

Abstract Number: 1096 • 2012 ACR/ARHP Annual Meeting
Lower Income Paradoxically Associated with Better Patient-Reported Outcomes After Knee Arthroplasty in the U.S
Jasvinder A. Singh¹ and David Lewallen², ¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ²Orthopedics, Mayo Clinic college of medicine, Rochester
Background/Purpose: To assess whether income is associated with patient-reported outcomes (PROs) after primary total knee arthroplasty (TKA).Methods: We used the prospectively collected data from…
Abstract Number: 1089 • 2012 ACR/ARHP Annual Meeting
The Number of Ruptured Tendons As a Prognostic Factor for Reconstructing Extensor Tendon Rupture in Patients with Rheumatoid Arthritis
Yu Sakuma¹, Kensuke Ochi¹, Takuji Iwamoto¹, Shinji Yoshida², Asami Saitou¹, Katsunori Ikari¹ and Shigeki Momohara¹, ¹Department of orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Extensor tendon rupture seen in patients with rheumatoid arthritis (RA) is usually surgically treated in combination with extensor tendon reconstruction and wrist arthroplasty. However,…
Abstract Number: 1093 • 2012 ACR/ARHP Annual Meeting
Obesity Is Not a Risk Factor for Poor Pain and Function Two Years After Total Knee Replacement
Lisa A. Mandl¹, Mark P. Figgie², Alejandro Gonzalez Della Valle³, Michael Alexiades³ and Susan M. Goodman¹, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Orthopedics, Hospital for Special Surgery, New York, NY, ³Orthopaedics, Hospital for Special Surgery, New York, NY
Background/Purpose: Almost 90% of referring physicians think obesity increases the likelihood of poor outcomes after total knee replacement (TKR). However, current data are conflicting. The…
Abstract Number: 1095 • 2012 ACR/ARHP Annual Meeting
Metal Concentrations in Patients with Failed Metal-On-Metal Hip Prostheses Determine the Inflammatory Phenotype in Peri-Implant Tissue
Erja-Leena Paukkeri¹, Riku Korhonen¹, Antti Eskelinen², Marko Pesu³, Kaija Vasama⁴, Teemu Moilanen² and Eeva Moilanen¹, ¹The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland, ²Coxa Hospital for Joint Replacement, Tampere, Finland, ³Immunoregulation, Institute of Biomedical Technology, University of Tampere, Tampere, Finland, ⁴Fimlab Laboratories, Tampere, Finland
Background/Purpose: Hip arthroplasty is the standard treatment of a painful hip destruction in rheumatoid arthritis and osteoarthritis. The use of metal-on-metal (MoM) bearing surfaces in…
Abstract Number: 2649 • 2012 ACR/ARHP Annual Meeting
Trends in US Arthroplasty Rates 1991-2005: Patients with Inflammatory Arthritis Continue to Require Joint Replacement
Christina Mertelsmann-Voss¹, Ting Jung Pan², Stephen L. Lyman³, Mark P. Figgie⁴ and Lisa A. Mandl⁵, ¹Pediatric Rheumatology, Hospital for Special Surgery, Cornell University, New York, NY, ²Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, ³Research, Hospital Special Surgery, New York, NY, ⁴Orthopedics, Hospital for Special Surgery, New York, NY, ⁵Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Overall rates of total joint replacement surgeries (TJR) have increased dramatically over the past decades. By contrast, TJR rates among patients with rheumatoid arthritis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].